1. Medtech Insight

Source: 3 Former Obama US CMS Officials Being Considered To Lead Biden’s Medicare Agency

The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.

From left, Chiquita Brooks-LaSure, Andy Slavitt and Jon Blum are being considered as CMS administrator, Medtech Insight has learned.
From left, Chiquita Brooks-LaSure, Andy Slavitt and Jon Blum are being considered as CMS administrator, Medtech Insight has learned • Source: Manatt/CMS

When it comes to the question of who should succeed Seema Verma as head of the US Centers for Medicare and Medicaid Services (CMS), the chatter seems to be centered around three individuals who previously served at the agency under the Obama administration, a source with knowledge of the discussions told Medtech Insight.

Another characteristic that seems to bind these individuals together is that, even after their work in government, they have shown to be health care advocates focused on serving the underprivileged....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.